Pune, India -- (SBWIRE) -- 02/09/2018 -- Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) and Forecast by 2024.

Global Hemostats Market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.

Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market

Report Segmentation:

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type's thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats Market Report is also segmented based on indications type into wound closure and surgery

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.

Geographical Segmentation:

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.

Inquiry Before Buying about this Report Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market

The global hemostats market is highly concentrated market with major key players and local players to cater the domestic market. Ethicon US LLC dominated the hemostats market accounting for the highest market share in 2016, followed by Pfizer Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom'Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global hemostats market in 2016.

ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):

Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.

Recent developments:

- In June, 2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable hemostat. This hemostat powder will help surgeons to have a simple and predictable adjunctive hemostatic solution to control continuous oozing on broad or raw surfaces.
In August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve patient's condition through Ethicon surgical products.

Pfizer:

Founded in 1849 and headquartered in New York, U.S., Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients' lives, and in addition products for the end user health care. The EH segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems, inadditon to research and development.

View Full Report Visit @ http://databridgemarketresearch.com/reports/global-hemostats-market/

TABLE OF CONTENTS:

- INTRODUCTION
- MARKET SEGMENTATION
- MARKET OVERVIEW
- PREMIUM INSIGHTS
- REGULATORY

- REIMBURSEMENT
- EXECUTIVE SUMMARY
- GLOBAL HEMOSTATS MARKET, BY TYPE

- GLOBAL HEMOSTATS MARKET,BY APPLICATION
- GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL
- GLOBAL HEMOSTATS MARKET, BY END USER
- GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY
12.1. OVERVIEW

12.2. NORTH AMERICA

12.3. EUROPE

12.4. ASIA-PACIFIC (APAC)

12.5. SOUTH AMERICA

12.6. MEA

- GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE
13.1. COMPANY SHARE ANALYSIS: GLOBAL

13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

13.3. COMPANY SHARE ANALYSIS: EUROPE

13.4. COMPANY SHARE ANALYSIS: APAC

- COMPANY PROFILES
14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)

14.2. PFIZER

14.3. C.R BARD

14.4. BAXTER

14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)

14.5.1. COMPANY OVERVIEW

14.5.2. REVENUE ANALYSIS

14.5.3. PRODUCT PORTFOLIO

14.5.4. RECENT DEVELOPMENTS

14.6. B.BRAUN MELSUNGEN AG

14.6.1. COMPANY OVERVIEW

14.6.2. REVENUE ANALYSIS

14.6.3. PRODUCT PORTFOLIO

14.6.4. RECENT DEVELOPMENTS

14.7. 3-D MATRIX LTD

14.7.1. COMPANY OVERVIEW

14.7.2. REVENUE ANALYSIS

14.7.3. PRODUCT PORTFOLIO

14.7.4. RECENT DEVELOPMENTS

14.8. RESORBA MEDICAL GMBH

14.8.1. COMPANY OVERVIEW

14.8.2. REVENUE ANALYSIS

14.8.3. PRODUCT PORTFOLIO

14.8.4. RECENT DEVELOPMENTS

14.9. ANIKA THERAPEUTICS, INC.

14.9.1. COMPANY OVERVIEW

14.9.2. REVENUE ANALYSIS

14.9.3. PRODUCT PORTFOLIO

14.9.4. RECENT DEVELOPMENTS

14.10. BIOM'UP

14.10.1. COMPANY OVERVIEW

14.10.2. REVENUE ANALYSIS

14.10.3. PRODUCT PORTFOLIO

14.10.4. RECENT DEVELOPMENTS

14.11. CRYOLIFE, INC.

14.11.1. COMPANY OVERVIEW

14.11.2. REVENUE ANALYSIS

14.11.3. PRODUCT PORTFOLIO

14.11.4. RECENT DEVELOPMENTS

14.12. EQUIMEDICAL

14.12.1. COMPANY OVERVIEW

14.12.2. REVENUE ANALYSIS

14.12.3. PRODUCT PORTFOLIO

14.12.4. RECENT DEVELOPMENTS

14.13. HEMOSTASIS, LLC

14.13.1. COMPANY OVERVIEW

14.13.2. REVENUE ANALYSIS

14.13.3. PRODUCT PORTFOLIO

14.13.4. RECENT DEVELOPMENTS

14.14. MEDTRADE PRODUCTS LIMITED

14.14.1. COMPANY OVERVIEW

14.14.2. REVENUE ANALYSIS

14.14.3. PRODUCT PORTFOLIO

14.14.4. RECENT DEVELOPMENTS

14.15. STRYKER

14.15.1. COMPANY OVERVIEW

14.15.2. REVENUE ANALYSIS

14.15.3. PRODUCT PORTFOLIO

14.15.4. RECENT DEVELOPMENTS

14.16. ARCH THERAPEUTICS, INC.

14.16.1. COMPANY OVERVIEW

14.16.2. REVENUE ANALYSIS

14.16.3. PRODUCT PORTFOLIO

14.16.4. RECENT DEVELOPMENTS

14.17. INTEGRA LIFESCIENCES CORPORATION

14.17.1. COMPANY OVERVIEW

14.17.2. REVENUE ANALYSIS

14.17.3. PRODUCT PORTFOLIO

14.17.4. RECENT DEVELOPMENTS

14.18. ALTAYLAR MEDICAL

14.18.1. COMPANY OVERVIEW

14.18.2. REVENUE ANALYSIS

14.18.3. PRODUCT PORTFOLIO

14.18.4. RECENT DEVELOPMENTS

14.19. BIOCER ENTWICKLUNGS-GMBH

14.19.1. COMPANY OVERVIEW

14.19.2. REVENUE ANALYSIS

14.19.3. PRODUCT PORTFOLIO

14.19.4. RECENT DEVELOPMENTS

14.20. SMI (STARCH MEDICAL)

14.20.1. COMPANY OVERVIEW

14.20.2. REVENUE ANALYSIS

14.20.3. PRODUCT PORTFOLIO

14.20.4. RECENT DEVELOPMENTS

Related Report

Global Hernia Repair Devices Market – Industry Trends and Forecast to 2024

Global Hernia Repair Devices Market By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-hernia-repair-devices-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com